News

Article

Clinical Quiz: Active Oligoarthritis Treatment Recommendations from 2021 ACR JIA Guidelines

Test your knowledge of active oligoarthritis treatment recommendations from the 2021 ACR guideline on JIA with this quiz.

Oligoarthritis, characterized as juvenile idiopathic arthritis (JIA) presenting with involvement of ≤ 4 joints without systemic manifestations, is the most common type of JIA, affecting approximately half of patients.

In the first in a series of clinical quizzes based on the American College of Rheumatology’s 2021 Guideline for the Treatment of Juvenile Idiopathic Arthritis, we focus on initial and subsequent treatment recommendations for patients with active oligoarthritis.

What is the recommended initial therapy for active oligoarthritis in JIA?


Related Videos
Marcelo Kugelmas, MD | Credit: South Denver Gastroenterology
John Tesser, MD, Adjunct Assistant Professor of Medicine, Midwestern University, and Arizona College of Osteopathic Medicine, and Lecturer, University of Arizona Health Sciences Center, and Arizona Arthritis & Rheumatology Associates
Brigit Vogel, MD: Exploring Geographical Disparities in PAD Care Across US| Image Credit: LinkedIn
Eric Lawitz, MD | Credit: UT Health San Antonio
| Image Credit: X
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Ahmad Masri, MD, MS | Credit: Oregon Health and Science University
Stephen Nicholls, MBBS, PhD | Credit: Monash University
Marianna Fontana, MD, PhD: Nex-Z Shows Promise in ATTR-CM Phase 1 Trial | Image Credit: Radcliffe Cardiology
Zerlasiran Achieves Durable Lp(a) Reductions at 60 Weeks, with Stephen J. Nicholls, MD, PhD | Image Credit: Monash University
© 2024 MJH Life Sciences

All rights reserved.